Ounallah-Saad et al., 2014 - Google Patents
Genetic or pharmacological reduction of PERK enhances cortical-dependent taste learningOunallah-Saad et al., 2014
View PDF- Document ID
- 16592463997544601109
- Author
- Ounallah-Saad H
- Sharma V
- Edry E
- Rosenblum K
- Publication year
- Publication venue
- Journal of Neuroscience
External Links
Snippet
Protein translation initiation is controlled by levels of eIF2α phosphorylation (p-eIF2α) on Ser51. In addition, increased p-eIF2α levels impair long-term synaptic plasticity and memory consolidation, whereas decreased levels enhance them. Levels of p-eIF2α are determined …
- 230000013016 learning 0 title abstract description 40
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ounallah-Saad et al. | Genetic or pharmacological reduction of PERK enhances cortical-dependent taste learning | |
Panicker et al. | Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson’s disease | |
Jais et al. | PNOCARC neurons promote hyperphagia and obesity upon high-fat-diet feeding | |
Park et al. | Microglial MERTK eliminates phosphatidylserine‐displaying inhibitory post‐synapses | |
Pryor et al. | Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington’s disease | |
Kawai et al. | Area-specific regulation of quiescent neural stem cells by Notch3 in the adult mouse subependymal zone | |
Toyo-Oka et al. | 14-3-3ε and ζ regulate neurogenesis and differentiation of neuronal progenitor cells in the developing brain | |
Su et al. | Atg5-and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine | |
Su et al. | Lithium, a common drug for bipolar disorder treatment, regulates amyloid-β precursor protein processing | |
Zheng et al. | A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies | |
Cheng et al. | SUMO-specific protease 1 is essential for stabilization of HIF1α during hypoxia | |
Kaneko et al. | Casein kinase 1 suppresses activation of REST in insulted hippocampal neurons and halts ischemia-induced neuronal death | |
Lee et al. | Regulator of G-protein signaling-10 negatively regulates NF-κB in microglia and neuroprotects dopaminergic neurons in hemiparkinsonian rats | |
Hsiao et al. | Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo | |
Segarra‐Mondejar et al. | Synaptic activity‐induced glycolysis facilitates membrane lipid provision and neurite outgrowth | |
Bouhamdani et al. | A Compendium of Information on the Lysosome | |
Mabb et al. | Topoisomerase 1 regulates gene expression in neurons through cleavage complex-dependent and-independent mechanisms | |
Chen et al. | CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory | |
Sałaciak et al. | The calcium/calmodulin-dependent kinases II and IV as therapeutic targets in neurodegenerative and neuropsychiatric disorders | |
Huang et al. | CRL4DCAF2 negatively regulates IL-23 production in dendritic cells and limits the development of psoriasis | |
Ha et al. | A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot–Marie–Tooth disease type 1A | |
López-Murcia et al. | Acute complexin knockout abates spontaneous and evoked transmitter release | |
Khlghatyan et al. | Fxr1 regulates sleep and synaptic homeostasis | |
Yang et al. | Protein phosphatase-1 inhibitor-2 is a novel memory suppressor | |
Linares et al. | SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALS |